World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
28832
World Ranking
13610
National Ranking
6916

Rachel Schiff publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Rachel Schiff sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 562 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Rachel Schiff D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Rachel Schiff sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Rachel Schiff is affiliated with Baylor College of Medicine in the United States. Their research spans medicine and biochemistry, genetics and molecular biology, with significant contributions to oncology and molecular biology subfields. Their work also encompasses pulmonary and respiratory medicine, radiology, nuclear medicine and imaging, and cancer research.

Their research topics focus predominantly on HER2/EGFR in cancer research, advanced breast cancer therapies, monoclonal and polyclonal antibodies research, cancer-related molecular pathways, cancer treatment and pharmacology, FOXO transcription factor regulation, and cancer genomics and diagnostics.

The scientist has published extensively in several notable venues including:

  • Cancer Research
  • Clinical Cancer Research
  • Journal of Clinical Oncology
  • The FASEB Journal
  • UNC Libraries

Rachel Schiff has frequently collaborated with several coauthors, including:

  • Mothaffar F. Rimawi
  • Jamunarani Veeraraghavan
  • Sarmistha Nanda
  • Carmine De Angelis
  • Xiaoyong Fu

Their recent papers include:

  • HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis, 2020, Cancer Treatment Reviews
  • Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance, 2020, Nature Cell Biology
  • Microscaled proteogenomic methods for precision oncology, 2020, Nature Communications
  • The bone microenvironment increases phenotypic plasticity of ER+ breast cancer cells, 2021, Developmental Cell
  • Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition, 2020, Science Advances

Best Publications

  • Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer.

    Jiang Shou;Suleiman Massarweh;C. Kent Osborne;Alan E. Wakeling

  • Mechanisms of Endocrine Resistance in Breast Cancer

    C. Kent Osborne;Rachel Schiff

  • Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast Cancer

    C. Kent Osborne;Valerie Bardou;Torsten A. Hopp;Gary C. Chamness

  • Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes

    Robert M. Lavinsky;Kristen Jepsen;Thorsten Heinzel;Joseph Torchia

  • The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo

    Kristen L. Meerbrey;Guang Hu;Jessica D. Kessler;Kevin Roarty

  • HER2: biology, detection, and clinical implications.

    Carolina Gutierrez;Rachel Schiff

  • Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance

    Grazia Arpino;Lisa Wiechmann;C. Kent Osborne;Rachel Schiff

  • Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine Therapy

    Xiaojiang Cui;Rachel Schiff;Grazia Arpino;C. Kent Osborne

  • ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer

    Rinath Jeselsohn;Gilles Buchwalter;Carmine De Angelis;Myles Brown

  • Molecular Changes in Tamoxifen-Resistant Breast Cancer: Relationship Between Estrogen Receptor, HER-2, and p38 Mitogen-Activated Protein Kinase

    M. Carolina Gutierrez;Simone Detre;Stephen Johnston;Syed K. Mohsin

  • Estrogen Receptor–Positive, Progesterone Receptor–Negative Breast Cancer: Association With Growth Factor Receptor Expression and Tamoxifen Resistance

    Grazia Arpino;Heidi Weiss;Adrian V. Lee;Rachel Schiff

  • Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function

    Suleiman Massarweh;C. Kent Osborne;Chad J. Creighton;Lanfang Qin

  • Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer.

    C. Kent Osborne;Jiang Shou;Suleiman Massarweh;Rachel Schiff

  • Cross-Talk between Estrogen Receptor and Growth Factor Pathways as a Molecular Target for Overcoming Endocrine Resistance

    Rachel Schiff;Suleiman A. Massarweh;Jiang Shou;Lavina Bharwani

  • A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models

    Xiaomei Zhang;Sofie Claerhout;Aleix Prat;Lacey E. Dobrolecki

  • Estrogen-Receptor Biology: Continuing Progress and Therapeutic Implications

    C. Kent Osborne;Rachel Schiff

  • A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.

    Jessica D. Kessler;Kristopher T. Kahle;Kristopher T. Kahle;Tingting Sun;Kristen L. Meerbrey

  • Breast Cancer Endocrine Resistance How Growth Factor Signaling and Estrogen Receptor Coregulators Modulate Response

    Rachel Schiff;Suleiman Massarweh;Jiang Shou;C. Kent Osborne

  • MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis

    Atsushi Terunuma;Nagireddy Putluri;Prachi Mishra;Ewy A. Mathé

  • Au Nanomatryoshkas as Efficient Near-Infrared Photothermal Transducers for Cancer Treatment: Benchmarking against Nanoshells

    Ciceron Ayala-Orozco;Cordula Urban;Mark W. Knight;Alexander Skyrme Urban

Frequent Co-Authors

C. Kent Osborne
C. Kent Osborne Baylor College of Medicine
Susan G. Hilsenbeck
Susan G. Hilsenbeck Baylor College of Medicine
Chad J. Creighton
Chad J. Creighton Baylor College of Medicine
Chad A. Shaw
Chad A. Shaw Baylor College of Medicine
Myles Brown
Myles Brown Harvard University
Suzanne A. W. Fuqua
Suzanne A. W. Fuqua Baylor College of Medicine
Joe W. Gray
Joe W. Gray Oregon Health & Science University
Michael T. Lewis
Michael T. Lewis Baylor College of Medicine
Jorge S. Reis-Filho
Jorge S. Reis-Filho Memorial Sloan Kettering Cancer Center
Thomas F. Westbrook
Thomas F. Westbrook Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always require the traditional path. There are several online direct entry MSN programs for non-nurses, allowing career changers to fast-track into advanced nursing roles without a prior nursing degree.

For those concerned about competitiveness, knowing what is the easiest nursing program to get into can help you find options that align with your academic background and minimize application stress.

If you’re interested in healthcare but prefer non-clinical roles, many medical billing and coding schools online provide excellent training along with financial aid, leading to in-demand administrative positions.

Some students wish to avoid standardized testing. Luckily, you can find nursing schools that don’t require teas or hesi exams, opening doors to nursing education without the added barrier of entrance tests.

These flexible educational options can help you begin or advance a healthcare career, tailored to your skills, interests, and educational background.

Best Scientists Citing Rachel Schiff

Trending Scientists

Recently Published Articles